News & Updates

Back to All News

Bryn Mawr Hospital is first on the East Coast to offer potential new treatment alternative to patients with atrial fibrillation

March 24, 2016 In the News

Bryn Mawr Hospital, part of Main Line Health’s Lankenau Heart Institute, is the first center on the East Coast to enroll patients in the FDA-approved AMAZE clinical trial that is studying left atrial appendage (LAA) closure with the LARIAT Suture Delivery Device as an adjunct to ablation in patients with persistent and long-standing persistent atrial fibrillation (AF). See more from Hellenic News.